No Halo News · Sourced development
Peer-reviewed study documents Pelotonia-backed research infrastructure supporting a new proteomics method
A Nature Communications paper described a faster method for developing targeted protein assays from very small biological samples. The authors said the work was made possible partly through resources, expertise and support from the Pelotonia Institute for Immuno-Oncology, which is funded by the Pelotonia community and Ohio State. The research also received National Institutes of Health and Ohio State support.
Status matters. This page records a sourced development, not a completed No Halo investigation. An allegation is not a finding. Dismissals, settlements, judgments, corrections and final outcomes remain distinct.
Donor relevance
Why this matters
The paper provides peer-reviewed evidence that infrastructure supported by Pelotonia is being used in published scientific work that may improve immune and cancer-research measurement tools.
Attribution
Who reported or established this
The study authors credited the Pelotonia Institute for Immuno-Oncology in the paper's acknowledgments.
Evidence limits
What remains unverified
The paper does not isolate Pelotonia's financial contribution, establish that Pelotonia alone caused the result or demonstrate improved patient outcomes.
Right of reply
Organization response
No separate Pelotonia response to this specific paper was located in the consulted material.
Classification
How No Halo records this event
Event type: Independent Impact Evidence. Current state: Reported. No Halo preserves the current procedural state rather than treating every mention as a finding.
Published April 23, 2025 · Last verified September 16, 2026. See an error or a later outcome? Submit a correction or right of reply.